Pharmacy World and Science

, Volume 26, Issue 6, pp 346–352 | Cite as

Providing pharmacy services to care homes in Northern Ireland: a survey of community pharmacists’ views

  • Anna K. Schweizer
  • Carmel M. Hughes


Objective: This study sought to explore the views of community pharmacists as to their present and potential role in providing care to the residents of nursing and residential home in Northern Ireland.

Method: A structured questionnaire was developed and mailed to all community pharmacists in Northern Ireland (n = 508) on 2 occasions.

Results: A response rate of 50% was achieved. Over 40% of responding pharmacists (42.1%) were currently providing medication-related services to care homes for the elderly and 57.9% were not. Of those who were providing services, 50 to 80% were already providing advice to care homes regarding record-keeping, compliance devices, storage and administration of medicines and the use of more appropriate formulations. More than 75% of pharmacists who were not providing services to care homes for the elderly supported all services detailed in a checklist provided on the questionnaire. For pharmacists who were providing services to care homes, 89% agreed that they required access to an up-to-date medical history of care home residents. Over 60% of pharmacists who worked with care homes had experienced difficulties when ordering prescriptions from general practice surgeries. Just over 75% of all respondents stated that they wanted to be more involved in providing pharmaceutical services to care homes to the elderly.

Conclusion: Community pharmacists expressed enthusiasm for provision of services to care home residents. On-going developments in community pharmacy practice in the UK may facilitate the development of this role and may guide policy development for long-term care in other countries.

Care homes Community pharmacists’ views Community pharmacy Elderly Northern Ireland Pharmaceutical services 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 2.
    Greengross S, Murphy E, Quam L, Rochon P, Smith R. Aging: a subject that must be at the top of the world agendas. BMJ 1997; 315: 1029–30.Google Scholar
  2. 3.
    Wittenberg R, Pickard L, Comas-Herrera A, Davies B, Darton R. Demand for long-term care: projections of long-term care finance for elderly people. Canterbury, UK: Personal Social Services Research Unit, 1998.Google Scholar
  3. 4.
    Jacobzone S. Coping with aging: International challenges. Health Affairs 2000; 19: 213–25.CrossRefGoogle Scholar
  4. 5.
    Institute of Medicine. Improving the quality of care in nursing homes. Washington, DC: National Academy Press, 1986.Google Scholar
  5. 6.
    Braithwaite J. The challenge of regulating care for older people in Australia. BMJ 2001; 323: 443–6.CrossRefGoogle Scholar
  6. 7.
    Schmidt I, Claesson CB, Westerholm B, Nilsson LG, Svarstad BL The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998; 46: 77–82.Google Scholar
  7. 8.
    Klein B, Cook A. Concepts of quality in residential care and nursing homes: UK and German perspectives. Health Care Later Life 1998; 3: 47–57.Google Scholar
  8. 9.
    Nolan L, O’Malley K. The need for a more rational approach to drug prescribing for elderly people in nursing homes. Age Ageing 1989; 18: 52–6.Google Scholar
  9. 10.
    Hughes CM, Lapane KL, Mor V. Impact of legislation on nursing home care in the United States: lessons for the United Kingdom. BMJ 1999; 319: 1060–2.Google Scholar
  10. 11.
    Stokes JA. Introducing clinical pharmacy as a quality use of medicines intervention in residential aged care [dissertation]. Brisbane, Australia: University of Queensland, 2002.Google Scholar
  11. 12.
    Smith MA, Simpson JM, Benrimoj SI. General practitioner acceptance of medication review in Sydney nursing homes. J Pharm Pract Res 2002; 32: 227–31.Google Scholar
  12. 13.
    Tarn YH, Chou SF, Wang TY. Drug regimen review at nursing homes in Taiwan. Int Pharm World Congress 2002; 62: 78.Google Scholar
  13. 14.
    Hendrichs J, Hovel G, Lohbreier-Dorr J, Pardieck A, Puteanus U. Drug supply to nursing homes for the aged. Gesundheitswesen 2001; 63: 514–21.CrossRefGoogle Scholar
  14. 15.
    Spong L. Role of the pharmacist in nursing homes in northern Europe. Pharm J 1992; 249: 23–5.Google Scholar
  15. 16.
    Taylor B, Rihal D, Iles C. Nursing homes – an inspector calls or a pharmacist visits. Pharm J 1995; 254: 367.Google Scholar
  16. 17.
    Royal College of Physicans, Royal College of Nursing, and British Geriatrics Society. The health and care of older people in care homes – a comprehensive interdisciplinary approach.London: Royal College of Physicians, 2000.Google Scholar
  17. 18.
    Schweizer AK, Hughes CM. Nursing and residential care for the elderly in Northern Ireland: the contribution of the pharmacist. Pharm World Sci 2001; 23: 195–9.CrossRefGoogle Scholar
  18. 19.
    Hughes CM, Lapane KL. The drive for quality care in US nursing homes in the era of the Prospective Payment System. Drugs Aging 2002; 19: 623–31.Google Scholar
  19. 20.
    Hughes GF, McElnay JC, Hughes CM, McKenna P. Abuse/misuse of non-prescription drugs. Pharm World Sci 1999; 21: 251-5.CrossRefGoogle Scholar
  20. 21.
    Smith F. Survey Research: (1) Design, samples and response. Int J Pharm Pract 1997; 5: 152–66.Google Scholar
  21. 22.
    Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, Kwan I. Increasing response rates to postal questionnaires. BMJ 2002; 324: 1183–91.PubMedGoogle Scholar
  22. 23.
    Furniss L, Lloyd Craig SK, Burns A. Medication use in nursing homes for elderly people. Int J Geriatric Psych 1998; 13: 433–9.Google Scholar
  23. 24.
    Royal Pharmaceutical Society of Great Britain (RPSGB). The administration and control of medicines in care homes and children’s homes. London: RPSGB, 2003.Google Scholar
  24. 25.
    Morrision D, O’Kane SMA, Timoney M. Managing your medicine – a pharmacy service in Northern Ireland. Pharm J 2001; 267: 556–7.Google Scholar
  25. 26.
    Northern Health and Social Services Board. Policy for the control and administration of medicines in nursing, residential and children’s homes. Ballymena, UK: Northern Health and Social Services Board (NHSSB), 1998.Google Scholar
  26. 27.
    Bellingham C. Repeat dispensing schemes get going. Pharm J 2003; 271: 640.Google Scholar
  27. 28.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43.Google Scholar
  28. 29.
    Royal Pharmaceutical Society of Great Britain (RPSGB). Pharmacists – a vital contribution to the new NHS. London: RPSGB, 2002.Google Scholar
  29. 30.
    Fahey T, Montgomery AA, Barnes J, Protheroe J. Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ 2003; 326: 580–5.CrossRefGoogle Scholar
  30. 31.
    Hughes CM, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract 2003; 53: 600–6.Google Scholar
  31. 32.
    Department of Health. Pharmacy in the future – implementing the NHS Plan. A programme for pharmacy in the National Health Service. London: The Stationery Office, 2000.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Anna K. Schweizer
    • 1
  • Carmel M. Hughes
    • 2
  1. 1.The School of PharmacyQueen’s University BelfastBelfastNorthern Ireland
  2. 2.The School of PharmacyQueen’s University BelfastBelfastNorthern Ireland

Personalised recommendations